Close menu




November 27th, 2020 | 09:19 CET

BYD, Canadian Solar, Silver Viper - don't miss the start!

  • Investments
Photo credits: pixabay.com

The optimism for life in normality is growing more and more with the successful test results concerning the vaccines against the coronavirus. The administration of a vaccine, which is to be available to the general public from spring 2021 onwards, should make it possible to relax increasingly in everyday life. If one reads the daily news, the pandemic seems to be contained and thus controllable within a few months. The "victims" of this development are the crisis currencies gold and silver. After their highs, both precious metals and mining stocks are initially taking a breather - but a comeback is very likely.

time to read: 2 minutes | Author: Stefan Feulner
ISIN: CA8283341029 , CNE100000296 , CA1366351098

Table of contents:


    Further correction likely

    How quickly a correction can be completed has been seen in the oil price in recent weeks. Since the March low at USD 18.00, the black gold has posted a performance of over 150%. We see something similar on the gold chart. The long term upward chart is still intact. Since its high in early August at USD 2,069.70, the precious yellow metal has begun a correction below the USD 1,900.00 mark which was initially regained.

    Afterwards, however, the price fell below the significant mark, also due to the positive vaccine announcement. Currently, a battle with the support at USD 1,795.00 is taking place. If this falls, we expect a rapid descent to the critical support level of USD 1,747.00. This significant level should represent the target range. From there, the next move north should start with new highs in 2021.

    Mining stocks become attractive again

    At the same time, mining stocks are correcting. Considering that the big picture in the gold market continues to be positive, exciting stocks should be added to the watchlist right now. One value that stands out is the Canadian junior exploration Company Silver Viper Minerals Corp. The Campany's value corrected from its August highs of CAD 0.85 over 50% to now CAD 0.41 in the course of the gold downturn. Fundamentally, the Company is in a strong position. In September, a financing round was successfully completed, which raised a total of CAD 2.8 million for Silver Viper.

    The descendants of Pan American Silver

    The Canadians search for precious metals in Sonora, Mexico. The Company currently operates its La Virginia gold-silver project, formerly owned by Pan American Silver Corp. Drilling at La Virginia has identified a gold-silver vein up to 20 metres in diameter. The experienced management, also due to the financial resources now available, intends to test other drill-ready anomalies that Silver Viper has identified at the surface during the sampling program in addition to the existing projects. In a press release, CEO Steve Cope also anticipates further momentum that could further enhance the value of the Company later this year.

    Other successful divisions

    BYD is hungry. The Chinese Company, which has made a name for itself primarily as an electric car manufacturer, is also pushing the expansion of other promising lines of business. Less well known is that BYD has been active in the North American energy storage market since 2011. The Tesla competitor is now reporting great successes in energy storage in the USA. A promising partnership has been agreed with Canadian Solar. BYD will provide its advanced battery technology for the 100 MWAC Mustang solar power plant in Kings County, California and will supply a 75 MW energy storage system as a retrofit to the plant.

    The system was developed by Canadian Solar, which has been connected to the power grid since 2016. With the newly developed storage system, the solar energy generated during the day can be stored for use in the evening. The "Build your dream" Company was euphoric about the project: "We are pleased to be able to supply this large-scale solar and energy storage project, which is being fully developed by Canadian Solar and integrated into our proprietary battery technology."


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Stefan Feulner

    Stefan Feulner

    The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
    He is passionate about analyzing a wide variety of business models and investigating new trends.

    About the author



    Related comments:

    Commented by Carsten Mainitz on October 29th, 2026 | 05:31 CET

    Gold, Tickets, Turnarounds! Why Stock Pickers Should Take a Closer Look at DRC Gold, CTS Eventim and Mutares Now

    • Stock Picking
    • Alpha
    • Investments
    • Gold
    • Exploration
    • Acquisition
    • Activist Investor

    The stock market is no petting zoo. Investors seeking returns have to go hunting themselves. Stock picking is the art of finding tomorrow's winners before the rest of the market wakes up. Under the leadership of industry veteran Klaus Eckhof, DRC Gold is working to take a stake in a gold project in the northeast of the Democratic Republic of the Congo. This could take the company to a whole new level. CTS Eventim is attracting renewed attention thanks to an activist investor. This could boost the share price. Mutares has many irons in the fire. Who is ahead?

    Read

    Commented by Carsten Mainitz on October 28th, 2026 | 05:30 CET

    Sow First, Reap Later! Exciting Developments at MustGrow, Bayer and K+S – Who Is Best Positioned?

    • Agriculture
    • Innovations
    • Ecology
    • Organic farming
    • Mustard plant
    • Investments

    Created and Published on Behalf of MustGrow Biologics Corp.

    Fewer chemicals, healthier soils and higher yields. Agriculture is looking for solutions that combine environmental protection and economic viability. Political support appears to be emerging from Brussels. The EU plans to approve biological crop protection products more quickly and reduce the administrative burden. However, the Council and the European Parliament still need to reach an agreement. At least the direction is right, which could open new opportunities for companies like MustGrow. The Canadians develop mustard-based agricultural products and cooperate with Bayer on biological crop protection through a licensing partnership. The first development milestone payment was made under this partnership in the summer. Bayer's agricultural division focuses on seeds and crop protection. K+S supplies potassium- and magnesium-based fertilisers for agriculture. Ultimately, all three companies face similar challenges: new and existing products must improve yields per hectare while remaining economically viable for farmers. Which stock offers the most value for investors?

    Read

    Commented by Armin Schulz on October 27th, 2026 | 05:21 CET

    Pharma Stocks with a Future: Bayer, BioNxt Solutions and Novo Nordisk Expand Their Pipelines

    • Bayer
    • BioNxt Solutions
    • Novo Nordisk
    • Investments
    • Active ingredients
    • Dosage forms
    • Thin film
    • Orally disintegrating film
    • Cladribine
    • Diabetes
    • Obesity
    • Weight-loss pill

    No pharmaceutical company can rely on its bestsellers forever. Eventually, patent protection expires, generic manufacturers enter the market, and margins come under pressure. Companies that fail to replenish their product pipelines risk being left behind. That is why substantial sums are currently flowing into new active ingredients, manufacturing facilities and innovative drug delivery methods. Bayer plans to invest USD 2.2 billion in a pharmaceutical plant in Ohio. Smaller developers such as BioNxt Solutions are exploring new formulations and delivery methods for established active ingredients. At the end of September, Novo Nordisk agreed to license an oral drug candidate, including an upfront payment of USD 300 million. We take a closer look at Bayer, BioNxt Solutions and Novo Nordisk.

    Read